Related Experiment Video
Updated: Aug 16, 2026

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
Slowly developing activation block of cardiac sodium channels by a lidocaine analog, transcainide
1Laboratory of Physiology, University of Leuven, Belgium.
Abstract:
The working mechanism of Na+ channel block by a lidocaine analog, transcainide, was investigated. The Na+ channel block was measured directly by recording the slowly inactivating Na+ current under voltage clamp conditions in rabbit cardiac Purkinje fibers and indirectly by using the maximal rate of depolarization as an index of Na+ current in guinea pig trabecular muscles. At a concentration of 10(-7) M, transcainide was found to bind uniquely to the activated state of the channel and not to the rested or inactivated state. The block was markedly frequency dependent. The kinetics at 37 degrees C was extremely slow with time constants for onset of block ranging between 36 min at a frequency between 0.5 s-1 and 2.2 min at a frequency of 4 s-1; time constant for recovery from block was 32 min as measured by the single stimulus method but became shorter the higher the frequency. It is concluded that transcainide is not essentially different from other antiarrhythmics of the local anesthetic type, but is characterized by very slow kinetics of binding and unbinding to the activated "open" Na+ channel.
Related Concept Videos
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Heart Failure Drugs: Inotropic Agents
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials

